Article
Patient stratification in myelodysplastic syndromes: how a puzzle may become a map.
Hematology. American Society of Hematology. Education Program - 4 Dec 2020
Kubasch Anne Sophie, Platzbecker Uwe
Abstract excerpt
Heterogeneity is the disease-defining epithet of myelodysplastic syndromes (MDS), a clonal disorder of hematopoietic stem and progenitor cells. During the last decade, significant progress has been made to better understand the diversity of clinical, molecular, cellular, and immunological factors that are bound to the prognosis and outcomes of patients with MDS. Despite the rapid generation of all of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.